![Icon depicting a video play button](https://biologics.catalent.com/wp-content/uploads/sites/2/2023/03/video.png)
UpTempo℠ AAV Platform Process Accelerates Time From Gene To Clinic
Summary: Catalent’s UpTempo AAV platform process offers clients accelerated timelines for producing their clinical materials. The scalable, CGMP-ready platform process can significantly reduce the time from gene to clinic through a simplified supply chain, increased development and manufacturing efficiencies, and standardized documentation.